Eur Rev Med Pharmacol Sci 2025; 29 (5): 221-221
DOI: 10.26355/eurrev_202505_37227

Retraction Note: MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway

X.-S. Bai, G. Bai, L.-D. Tang, Y. Li, Y. Huan, H. Wang

Department of Gastroenterology, Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China


The article “MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway” by X.-S. Bai, G. Bai, L.-D. Tang, Y. Li, Y. Huan, H. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24 (5): 2640-2646–DOI: 10.26355/eurrev_202003_20533–PMID: 32196614 has been retracted in accordance with the Publisher and the Editor in Chief.

Following some concerns raised by a third party regarding possible overlaps and duplication in Figure 2, the Editor in Chief has started an investigation to assess the validity of the concerns, as well as a possible Figure manipulation.

The journal’s investigation revealed overlaps between panels “Model” and “miR-195 agomir” and between “Control” and “Model” of Figure 2.

The authors have been notified about the ongoing investigation and were asked to provide the original data, however, they have not responded to these communications.

Therefore, the manuscript is retracted for figure duplication and manipulation.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway

Free PDF Download

To cite this article

X.-S. Bai, G. Bai, L.-D. Tang, Y. Li, Y. Huan, H. Wang
Retraction Note: MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2025
Vol. 29 - N. 5
Pages: 221-221
DOI: 10.26355/eurrev_202505_37227

Publication History

Published online: 28 May 2025